Legend Holdings joined existing backers including Eli Lilly, Fidelity Biosciences and Fidelity for drug developer Innovent's series C

Norway-based Ultimovacs raised the funding through a share placement to investors including corporates Canica and Sundt.

Norway-based Ultimovacs raised the funding through a share placement to investors including corporates Canica and Sundt.

Dow Chemical exited the diagnostic testing company, which had raised $24m in total, through the acquisition.

Johnson & Johnson and Takeda are among the investors committing $28m to fund graduates from the Israel-based programme.

Mitsui has a led the round that took the Qualcomm-backed clinical testing software company's overall funding to $38m.

The fitness equipment company has co-launched an accelerator that will target health and wellness technology startups.